Comments
Dr. Reddy’s Laboratories Ltd has launched sorafenib tablets, a therapeutic generic equivalent of Nexavar (sorafenib) in the US market following approval by the US Food and Drug Administration (USFDA). The drug is used to treat certain types of cancer.
“We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients,” Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories Inc, said in a release.
The drug is available as 200 mg tablets in a bottle of 120.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.